1. Home
  2. Directory
  3. Oregon
  4. Portland
  5. Psychiatry Neurology
  6. NPI Profile
  7. Prescriptions 1467945006

REBECCA ANN ANTHONY MD
Prescription History 1467945006
Psychiatry & Neurology - Psychiatry in Portland, OR


Quality Rating: 87.76 out of 100 score

NPI Status: Active since June 08, 2018

Contact Information

5228 NE HOYT ST BLDG B3
PORTLAND, OR
ZIP 97213
Phone: (503) 215-4860
Fax: (971) 282-0091

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for REBECCA ANN ANTHONY MD, an active Psychiatry specialist practicing in Portland, OR. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 46 documented patient claims. Among these therapy options, the most frequently utilized medication is Bupropion Xl, which accounts for 17 claims alone.

Medication Index

B
E
M
No matching medications currently found on file.

Bupropion Xl

Generic Formulation: Bupropion HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 17
30-Day Fills 21.0
Days Supply 630
OR State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills70.6
Peer Average Days Supply2,101
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 51.4% less volume than the regional standard for practitioners inside OR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $824.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$48.51

State Avg Cost Per Claim

$38.50

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Bupropion is used to treat depression. It can improve your mood and feelings of well-being. It may work by helping to restore the balance of certain natural chemicals (neurotransmitters) in your brain.

Escitalopram Oxalate

Generic Formulation: Escitalopram OxalateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 16
30-Day Fills 27.0
Days Supply 780
OR State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills75.9
Peer Average Days Supply2,255
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 57.9% less volume than the regional standard for practitioners inside OR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $419.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$26.19

State Avg Cost Per Claim

$15.17

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder.

Therapeutic Applications

Escitalopram is used to treat depression and anxiety. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRI). It may improve your energy level and feelings of well-being and decrease nervousness.

Mirtazapine

Generic Formulation: MirtazapineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 13
30-Day Fills 19.0
Days Supply 570
OR State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills51.2
Peer Average Days Supply1,505
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.6% less volume than the regional standard for practitioners inside OR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $257.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.81

State Avg Cost Per Claim

$26.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Therapeutic Applications

Mirtazapine is used to treat depression. It improves mood and feelings of well-being. Mirtazapine is an antidepressant that works by restoring the balance of natural chemicals (neurotransmitters) in the brain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like REBECCA ANN ANTHONY MD provides transparency into local medical care patterns within Portland, OR.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Psychiatry** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.